Every sales hiring plan for 2027 rests on a claim that the business is ready to scale. I think boards and CROs should ask for the evidence behind that claim with the same rigour they apply to the revenue number, and Stage 2 Capital’s new funds give the clearest recent statement of why.
Stage 2 Capital announced on Nov. 10 that it has closed $100 million across Venture Fund IV and Catalyst IV. Venture Fund IV writes checks of $2 million to $5 million from Seed through Series A; Catalyst IV makes $200,000 investments in pre-seed companies. The firm pairs a venture partner with a partner from a go-to-market background, and it says its LP network includes more than 1,000 GTM leaders. It is also adding an MCP agent that matches portfolio founders with operators in that network who have recently solved the same problem.
The fund size made the headline. The sentence I would pin above every headcount review came from Mark Roberge, the firm’s co-founder and managing partner, who developed its Science of Scaling framework.
Advertisement
“We have well-established ways to measure revenue, but very little discipline around deciding when a company is actually ready to scale or how fast it should grow,” Roberge said in the announcement. He added: “Too often, boards rely on a playbook that worked for another company ten years ago, without considering whether it makes sense for the business in front of them.”
The case for hiring ahead of the evidence
The strongest argument against my position is that evidence arrives late. Ramp takes quarters, and a company that waits for clean data before hiring can watch a competitor take the market. Roberge names this risk himself: “Some scale too slowly and miss their window. Others scale before they’re ready and put the entire business at risk.” Hiring ahead of proof is sometimes the right bet, and no readiness test removes the need for judgment.
I accept that. My argument is narrower. A bet made on purpose, with the evidence it rests on written down, is a different decision from a bet made because last year’s plan carried a growth line and nobody asked what had changed. The first can be checked against results in two quarters. The second can only be defended.
What I would ask for before signing the plan
None of what follows is Stage 2’s framework; it is the evidence I would want on the table as a revenue leader, drawn from the data a sales team already holds.
Proof the current motion repeats
Before adding reps, show that the reps already hired are winning in a pattern: similar deal sizes, similar cycle lengths, similar reasons buyers chose the product. If the wins come from three founder-led deals and a lucky quarter, more reps will mostly add cost.
Ramp data from the last cohort
The plan should state how long the most recent hires took to reach productivity and what share of them got there. A hiring model that assumes a ramp the company has never achieved is a forecast built on a guess.
Pipeline that exists today
Coverage for the new capacity should be visible in the CRM now, by segment, instead of in a top-down market-size slide. If new reps will need to build their own pipeline from zero, the plan should say so and price the delay.
A trigger to slow down
The plan should name the result that would pause the next hiring wave. Boards are used to acceleration triggers. A deceleration trigger is what turns a playbook into a decision someone can revisit.
AI in the plan makes the question harder
Stage 2’s own release ties the firm’s model to AI: it now backs B2B AI companies and is putting an agent between founders and its operator network. Many 2027 sales plans will make a similar move, swapping some headcount for agents. That makes the readiness question harder. A plan that mixes reps and agents needs evidence for both, and adoption figures are a weak substitute, as I argued when I wrote that 100% AI adoption is a meaningless number. The hiring question has also changed at the top of the team, which is why the VP of sales interview has changed too.
Ashley Wilson, co-founder of Momentum, which Salesforce acquired, described what Stage 2 did as an investor in the release: “They helped us pressure-test when we truly had product-market fit and how fast to scale from there.” That pressure test is the step most hiring plans skip, and a CRO can run it internally before the board asks.
For this planning cycle, attach a one-page evidence sheet to the headcount request covering repeatability, last-cohort ramp, existing pipeline and the trigger to slow down. If the sheet is thin, hire less and say why. If it is strong, the board gets a plan it can hold the team to.
Source: Stage 2 Capital via PR Newswire
